MWNA
IVVD icon

Marshall Wace North America’s Invivyd IVVD Stock Holding History

Marshall Wace North America’s Portfolio IVVD Stock Details IVVD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.8M Buy
+42,640
New +$1.58M 0.01% 755

Other funds holding IVVD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace North America's IVVD Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Invivyd (IVVD) in Q3 2021: 42,640 shares worth $1.8M. The stake represents 0.01% of the portfolio and ranks #755 among its holdings.

67 funds tracked by Wall St. Rank hold IVVD as of Q3 2021.

  • Marshall Wace North America held 42,640 shares of Invivyd worth $1.8M as of Q3 2021.
  • Invivyd was a new Marshall Wace North America position in Q3 2021.
  • Invivyd made up 0.01% of Marshall Wace North America's portfolio in Q3 2021, its #755 holding.
  • 67 funds tracked by Wall St. Rank held Invivyd as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.